PUBLISHER: The Insight Partners | PRODUCT CODE: 2021156
PUBLISHER: The Insight Partners | PRODUCT CODE: 2021156
The pharmaceutical excipients market size is expected to grow from US$ 10.03 billion in 2025 to US$ 17.60 billion by 2034; it is projected to register a CAGR of 6.5% during 2026-2034. The surging demand for generic medications and advanced formulations, increasing research and development efforts in novel excipients, and growing biopharmaceuticals and biosimilars are noteworthy factors contributing to the expansion of the pharmaceutical excipients market size. Additionally, growing advancements in multifunctional and nanotechnology excipients, and integration of AI and 3D printing in excipient innovation are projected to bring new pharmaceutical excipients market trends in the near future.
The pharmaceutical excipients market now benefits from AI integration with 3D printing technology because these solutions enable scientists to create personalized formulation designs and production methods. AI algorithms use machine learning to study extensive excipient-API interaction databases, which helps them determine the best material combinations and speeds up research work while decreasing laboratory testing needs. AI models use their predictive capabilities to create dissolution profiles of excipients, which show how they will perform at different pH levels to create coatings for proton pump inhibitors that treat gastrointestinal disorders.
Complementing AI, 3D printing technologies enable the layer-by-layer fabrication of excipient matrices, creating personalized blends with precise spatial distributions of additives. The combination of binder jetting 3D printing technology and mannitol-powdered polyvinylpyrrolidone excipients creates polypills (multi-drug tablets with varying release rates), which elderly patients use to treat simultaneous hypertension and hyperlipidemia. AI-controlled 3D printing technology produces porous scaffolds from alginate-based excipients for biologics, which create tissue-engineered delivery systems that enhance vascularization in regenerative treatments for chronic wounds. The system uses advanced technologies to create complex delivery systems that use AI-based microneedle patches that contain gelatin-based excipients for insulin delivery through the skin, which provide better diabetes glucose level control. The combination of these two technologies enables hospitals to produce medical products on demand. In chronic conditions, such as oncology, AI predicts excipient synergies for 3D-printed implants that release chemotherapeutics gradually, minimizing toxicity, thereby emerging as a significant trend in the pharmaceutical excipients market.
End User-Based Insights
Based on end user, the pharmaceutical excipients market is segmented into pharma industries, biopharma industries, animal health, and other end user. The pharma industries segment held the largest pharmaceutical excipients market share in 2025. In the market, this segment makes extensive use of excipients as binders, fillers, disintegrants, lubricants, coatings, and preservatives in supporting key pharmaceutical manufacturing operations such as tablet compression, capsule filling, granulation, and liquid suspensions for oral, topical, injectable, and controlled-release dosage forms. This segment is likely to grow due to the continuous wave of patent expirations fueling the growth of generic drug markets, the rising incidence rate of chronic diseases in the global population due to the high prevalence rate of lifestyle disorders that necessitate long-term drug therapies, and the increasing need for drug delivery system innovations that necessitate the use of multifunctional and novel excipients. The increasing focus on quality by design concepts, patient-oriented drug formulations, and stringent pharmacopeial requirements for drug safety and efficacy also fuels the growth of this segment in the excipients market. Additionally, the increasing need for drug availability in the growing markets in the developing world continues to maintain a high growth rate in this segment of the excipients market, thereby fueling the pharmaceutical excipients market growth.
The World Health Organization, Pan American Health Organization, and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the pharmaceutical excipients market report.